InspireMD (NSPR)
(Real Time Quote from BATS)
$2.80 USD
-0.11 (-3.78%)
Updated Aug 19, 2024 03:18 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
Brokerage Reports
0 items in cart
InspireMD, Inc. [NSPR]
Reports for Purchase
Showing records 1 - 20 ( 21 total )
Company: InspireMD, Inc.
Industry: Medical - Instruments
Company: InspireMD, Inc.
Industry: Medical - Instruments
Company: InspireMD, Inc.
Industry: Medical - Instruments
A Transition Achieved in a Year Buffeted by COVID Winds; Maintain Buy and $1 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: InspireMD, Inc.
Industry: Medical - Instruments
3Q20 Results Shows a Return to Pre-COVID Levels but Challenges Likely in 2021; Reiterate Buy; Adjusting PT to $1
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: InspireMD, Inc.
Industry: Medical - Instruments
1Q20 Results and Update Show CGuard Standing Ready When the Healthcare System Improves; Reiterate Buy and $2 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: InspireMD, Inc.
Industry: Medical - Instruments
Tempering Near-Term Expectations but Expect Re-acceleration by YE20; Reit Buy and $2 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: InspireMD, Inc.
Industry: Medical - Instruments
Building a Foundation for Stronger Growth Continues; Reit Buy With a New Price Target of $2
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: InspireMD, Inc.
Industry: Medical - Instruments
3Q19 Results Suggest Fair Winds and Following Seas for CGuard; Reit Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: InspireMD, Inc.
Industry: Medical - Instruments
A Shift in the Winds Removes the 1Q Backlog; Reiterate Buy With an Adjusted PT of $5
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: InspireMD, Inc.
Industry: Medical - Instruments
Getting Past the Conventional Approach in Stroke; Initiate With a Buy Rating and $0.30 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: InspireMD, Inc.
Industry: Medical - Instruments
Termination of Coverage
Provider: Rodman & Renshaw, Co.
Company: InspireMD, Inc.
Industry: Medical - Instruments
Termination of Coverage
Provider: H.C. Wainwright & Co., Inc.
Company: InspireMD, Inc.
Industry: Medical - Instruments
Unearthing Gems in the Promised Land: An Overview of the Israeli Life Sciences Sector
Provider: H.C. Wainwright & Co., Inc.
Company: InspireMD, Inc.
Industry: Medical - Instruments
Unearthing Gems in the Promised Land: An Overview of the Israeli Life Sciences Sector
Provider: Rodman & Renshaw, Co.
Company: InspireMD, Inc.
Industry: Medical - Instruments
2016 1Q Results: CGuard Outlook Positive; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: InspireMD, Inc.
Industry: Medical - Instruments
2016 1Q Results: CGuard Outlook Positive; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: InspireMD, Inc.
Industry: Medical - Instruments
CGuard Expected to Gain Market Traction in 2016; Reiterate Buy with Lower PT
Provider: Rodman & Renshaw, Co.
Company: InspireMD, Inc.
Industry: Medical - Instruments
CGuard Expected to Gain Market Traction in 2016; Reiterate Buy with Lower $3 PT
Provider: H.C. Wainwright & Co., Inc.
Company: InspireMD, Inc.
Industry: Medical - Instruments
We are initiating coverage with a Buy rating and a 12-month price target of $4 per share.
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: InspireMD, Inc.
Industry: Medical - Instruments
We are initiating coverage with a Buy rating and a 12-month price target of $4 per share.
Provider: Rodman & Renshaw, Co.